Free-radical liver damage correction in mechanical jaundice
Alexander N. Belyaev,
Evgeny V. Boyarkin,
Sergey V. Kostin,
Pavel N. Parkin,
Denis V. Babas,
Sergey A. Belyaev https://doi.org/10.31146/1682-8658-ecg-203-7-165-170
Abstract
Objectives: The aim of this study was to evaluate the hepatoprotective activity of resveratrol in patients with morphofunctional liver disorders due to mechanical jaundice. Methods: The controlled mechanical jaundice was simulated on the rats under anesthesia by drainage of the choledochus and its plugging. In the control group decompression of the choledochus was performed on the 3rd day and intravenous infusion of 0,9% sodium chloride solution was administrated for 12 days. In the experimental group after billiar decompression, resveratrol was administered intravenously at a dose of 20 mg/kg. The following were studied: level of malondialdehyde, catalase, bilirubin, alanine aminotransferase (ALAT), aspartate aminotransferase; liver histology was performed. Results: Catalase was 3.9 times reliably increased, and the activity of malonic dialdehyde and ALAT was 2.0 and 3.6 times reliably decreased in experimental group compared to the control group. Microscopic shows edema and destruction of the liver were reduced, the architectonic of the liver lobules was recovered. Conclusion: Application of resveratrol in mechanical jaundice decreased the processes of free-radical oxidation and level of the liver cells cytolysis markers which morphologically was shown by edema reduction, restoration of the liver lobules structure.
About the Authors
Alexander N. Belyaev
National Research Mordovia State University
Russian Federation
Russian Federation
Evgeny V. Boyarkin
National Research Mordovia State University
Russian Federation
Russian Federation
Sergey V. Kostin
National Research Mordovia State University
Russian Federation
Russian Federation
Pavel N. Parkin
National Research Mordovia State University
Russian Federation
Russian Federation
Denis V. Babas
Mordovian Republican Central Clinical Hospital
Russian Federation
Russian Federation
Sergey A. Belyaev
National Research Mordovia State University
Russian Federation
Russian Federation
References
1. Chen H. L., Wu S. H., Hsu S. H., Liou B. Y., Chen H. L., Chang M. H. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases. J Biomed Sci. 2018;25:75. doi: 10.1186/s12929-018-0475-8
2. Pavlidis E. T., Pavlidis T. E. Pathophysiological consequences of obstructive jaundice and perioperative management. HBPD Int. 2018;17:17-21. doi: 10.1016/j.hbpd.2018.01.008
3. Gonzalez-Correa J.A., De La Cruz J. P., Martin-Aurioles E., Lopez-Egea M.A., Ortiz P., Sanchez de la Cuesta F. Effects of S-adenosyl-L-methionine on hepatic and renal oxidative stress in an experimental model of acute biliary obstruction in rats. Hepatology. 1997;26:121-7.
4. Burkitt M. J., Duncan J. Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage: evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mechanism of action. Arch Biochem Biophys. 2000;381(2):253-263. doi: 10.1006/abbi.2000.1973
5. Sgambato A., Ardito R., Faraglia B., Boninsegna A., Wolf F. I., Cittadini A. Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutat Res. 2001;496(1-2):171-180. doi: 10.1016/s1383-5718(01)00232-7
6. Amiot M. J., Riva C., Vinet A. Effects of dietary polyphenols on metabolic syndrome features in humans: a systematic review. Obes Rev. 2016;17(7):573-586. doi: 10.1111/obr.12409
7. Bunaciu R. P., Yen A. Resveratrol and Malignancies. Curr Pharmacol Rep. 2015;1(4):266-271. doi: 10.1007/s40495-015-0030-1
8. Udenigwe C. C., Ramprasath V. R., Aluko R. E., Jones P. J. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev. 2008;66(8):445-454. doi: 10.1111/j.1753-4887.2008.00076.x
9. Heebøll S., Thomsen K. L., Pedersen S. B., Vilstrup H., George J., Grønbæk H. Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease. World J Hepatol. 2014;6(4):188-198. doi: 10.4254/wjh.v6.i4.188
10. Ferramosca A., Di Giacomo M., Zara V. Antioxidant dietary approach in treatment of fatty liver: New insights and updates. World J Gastroenterol. 2017;23(23):4146-4157. doi: 10.3748/wjg.v23.i23.4146
11. Muriel P., Rivera-Espinoza Y. Beneficial drugs for liver diseases. J Appl Toxicol. 2008;28(2):93-103. doi: 10.1002/jat.1310
12. Wang Y., Jiang Y., Fan X., Tan H., Zeng H., Wang Y., Chen P., Huang M., Bi H. Hepato-protective effect of resveratrol against acetaminophen-induced liver injury is associated with inhibition of CYP-mediated bioactivation and regulation of SIRT1-p53 signaling pathways. Toxicol Lett. 2015;236(2):82-89. doi: 10.1016/j.toxlet.2015.05.001
13. Ara C., Kirimlioglu H., Karabulut A. B., Coban S., Ay S., Harputluoglu M., Kirimlioglu V., Yilmaz S. Protective effect of resveratrol against oxidative stress in cholestasis. J Surg Res. 2005;127(2):112-117. doi: 10.1016/j.jss.2005.01.024
14. Kirimlioglu V., Ara C., Yilmaz M., et al. Resveratrol, a red wine constituent polyphenol, protects gastric tissue against the oxidative stress in cholestatic rats. Dig Dis Sci. 2006;51(2):298-302. doi: 10.1007/s10620-006-3128-9
15. Hussein M. A. Prophylactic effect of resveratrol against ethinylestradiol-induced liver cholestasis. J Med Food. 2013;16(3):246-254. doi: 10.1089/jmf.2012.0183
16. Chan C. C., Cheng L. Y., Lin C. L., Huang Y. H., Lin H. C., Lee F. Y. The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury. Mol Nutr Food Res. 2011;55(12):1841-1849. doi:10.1002/mnfr.201100374
17. Konyukhova S. G., et al. Lipid peroxidation and methods for determining lipid peroxidation products in biological media. Laboratory business. 1989; (9): 40-46. (In Russ.) @@Конюхова С. Г. Перекисное окисление липидов и методы определения продуктов липопероксидации в биологических средах / С. Г. Конюхова, А. А. Маркин, Т. Н. Федорова // Лабораторное дело. - 1989. - № 9. - С. 40-46.
18. Korolyuk M. A., et al. Method for determining catalase activity. Laboratory business. 1988;(1):16-17. (In Russ.) @@Королюк М. А. Метод определения каталазной активности / М. А. Королюк, И. Г. Иванова, Майорова, В. Е. Токарев // Лабораторное дело. - 1988. - № 1. - С. 16-17.
19. Mohamadnejad M., Tavangar S. M., Sotoudeh M., et al. Histopathological Study of Chronic Hepatitis B: A Comparative Study of Ishak and METAVIR Scoring Systems.Int J Organ Transplant Med. 2010;1(4):171-6. PMID: 25013582; PMCID: PMC4089240.
20. Lin T. K., Huang L. T., Huang Y. H., Tiao M. M., Tang K. S., Liou C. W. The effect of the red wine polyphenol resveratrol on a rat model of biliary obstructed cholestasis: involvement of anti-apoptotic signalling, mitochondrial biogenesis and the induction of autophagy. Apoptosis. 2012;17(8):871-879. doi: 10.1007/s10495-012-0732-3
21. Tunali-Akbay T., Sehirli O., Ercan F., Sener G. Resveratrol protects against methotrexate-induced hepatic injury in rats. J Pharm Pharm Sci. 2010;13(2):303-10. doi: 10.18433/j30k5q
22. Wang T., Zhou Z. X., Sun L. X., et al. Resveratrol effectively attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms. Acta Pharmacol Sin. 2014;35(12):1527-1536. doi: 10.1038/aps.2014.119
23. Ara C., Kirimlioglu H., Karabulut A. B., Coban S., Ay S., Harputluoglu M., Kirimlioglu V., Yilmaz S. Protective effect of resveratrol against oxidative stress in cholestasis. J Surg Res. 2005 Aug;127(2):112-7. doi: 10.1016/j.jss.2005.01.024
24. Dolezelova E., Prasnicka A., Cermanova J., et al. Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats. World J Gastroenterol. 2017;23(43):7678-7692. doi: 10.3748/wjg.v23.i43.7678
Review
For citations:
Belyaev A.N., Boyarkin E.V., Kostin S.V., Parkin P.N., Babas D.V., Belyaev S.A. Free-radical liver damage correction in mechanical jaundice. Experimental and Clinical Gastroenterology. 2022;(7):165-170. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-203-7-165-170
Views:
495
Email this article 